Inventor · Mukilteo, WA, US

Mark D. Hylarides

15Patents
6h-index
19Co-inventors
63Inventor score

Filing activity: Apr 9, 1984 → Jun 19, 2008

Most-cited inventions

PatentTitleAreaCited byStatus
US5563250A Cleavable conjugates for the delivery and release of agents in native form Human Necessities 38 Expired
US5057301A Modified cellular substrates used as linkers for increased cell retention of diagnostic and therapeutic agents Human Necessities 34 Expired
US6358710B1 Humanized antibodies that bind to the antigen bound by antibody NR-LU-13 Chemistry; Metallurgy 28 Expired
US6767531B2 High dose radionuclide complexes for bone marrow suppression Human Necessities 16 Expired
US5017693A Methods for introducing a sulfhydryl amino or hydroxyl groups to a compound Human Necessities 15 Expired
US5141648A Methods for isolating compounds using cleavable linker bound matrices Emerging Cross-Sectional Technologies 14 Expired
US7097823B2 High dose radionuclide complexes for bone marrow suppression Human Necessities 6 Expired
US7070759B2 High dose radionuclide complexes for bone marrow suppression Human Necessities 5 Expired
US7696331B2 High dose radionuclide complexes for bone marrow treatment Human Necessities 5 Active
US7378077B2 High dose radionuclide complexes for bone marrow suppression Human Necessities 3 Active
US7408046B2 Treatment of bone-associated cancers Human Necessities 3 Expired
US5911969A Pretargeting protocols for enhanced localization of active agents to target sites Emerging Cross-Sectional Technologies 3 Expired
US4676932A Synthesis of 1-haloestradiols Chemistry; Metallurgy 2 Expired
US4577046A Deamination of aromatic amines Chemistry; Metallurgy 1 Expired
US4584137A Synthesis of 1-haloestradiols Chemistry; Metallurgy 0 Expired

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.